Cardiac amyloidosis risk factors: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cardiac amyloidosis}} {{CMG}}; {{AE}} {{HK}} ==Overview== The most common risk factor for the development of primary amyloidosis is the presence of an underly...")
 
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
The most common [[risk factor]] for the development of primary amyloidosis is the presence of an underlying [[plasma cell dyscrasia]].  
The most common [[risk factor]] for the development of cardiac amyloidosis is the presence of an underlying [[plasma cell dyscrasia]].  
==Risk Factors==
==Risk Factors==
The most common [[risk factor]] for the development of primary amyloidosis is the presence of an underlying [[plasma cell dyscrasia]].<ref name="pmid4204196">{{cite journal |vauthors=Isobe T, Osserman EF |title=Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins |journal=N. Engl. J. Med. |volume=290 |issue=9 |pages=473–7 |date=February 1974 |pmid=4204196 |doi=10.1056/NEJM197402282900902 |url=}}</ref><ref name="pmid14567063">{{cite journal |vauthors=Lebowitz RA, Morris L |title=Plasma cell dyscrasias and amyloidosis |journal=Otolaryngol. Clin. North Am. |volume=36 |issue=4 |pages=747–64 |date=August 2003 |pmid=14567063 |doi= |url=}}</ref>  
The most common [[risk factor]] for the development of cardiac amyloidosis is the presence of an underlying [[plasma cell dyscrasia]].<ref name="pmid4204196">{{cite journal |vauthors=Isobe T, Osserman EF |title=Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins |journal=N. Engl. J. Med. |volume=290 |issue=9 |pages=473–7 |date=February 1974 |pmid=4204196 |doi=10.1056/NEJM197402282900902 |url=}}</ref><ref name="pmid14567063">{{cite journal |vauthors=Lebowitz RA, Morris L |title=Plasma cell dyscrasias and amyloidosis |journal=Otolaryngol. Clin. North Am. |volume=36 |issue=4 |pages=747–64 |date=August 2003 |pmid=14567063 |doi= |url=}}</ref>  


==References==
==References==

Latest revision as of 20:46, 30 October 2019

Cardiac amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis risk factors

CDC onCardiac amyloidosis risk factors

Cardiac amyloidosis risk factors in the news

Blogs on Cardiac amyloidosis risk factors

Directions to Hospitals Treating Cardiac amyloidosis

Risk calculators and risk factors for Cardiac amyloidosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

The most common risk factor for the development of cardiac amyloidosis is the presence of an underlying plasma cell dyscrasia.

Risk Factors

The most common risk factor for the development of cardiac amyloidosis is the presence of an underlying plasma cell dyscrasia.[1][2]

References

  1. Isobe T, Osserman EF (February 1974). "Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins". N. Engl. J. Med. 290 (9): 473–7. doi:10.1056/NEJM197402282900902. PMID 4204196.
  2. Lebowitz RA, Morris L (August 2003). "Plasma cell dyscrasias and amyloidosis". Otolaryngol. Clin. North Am. 36 (4): 747–64. PMID 14567063.

Template:WH Template:WS